Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.

Author: BrussJon, FleishakerDona, HiltyMilo, Naberhuis-StehouwerSharon, TregnaghiMiguel, WibleKenneth

Paper Details 
Original Abstract of the Article :
Skin and skin structure infections are common reasons for visits to pediatricians, accounting for up to 18%. Staphylococcus aureus and Streptococcus pyogenes are the most frequently isolated Gram-positive pathogens in uncomplicated skin infections. Increasingly outpatient infections involve antibiot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/01.inf.0000059403.21440.2c

データ提供:米国国立医学図書館(NLM)

Linezolid vs. Cefadroxil: Choosing the Right Antibiotic for Children's Skin Infections

Skin infections are common in children, and finding the right antibiotic is crucial for effective treatment. This study compares the effectiveness of linezolid and cefadroxil in treating skin and skin structure infections in children. The researchers aim to determine which antibiotic is more effective and safe for treating these infections, especially those caused by antibiotic-resistant bacteria.

Linezolid: A Strong Contender for Resistant Infections

The study found that linezolid was more effective than cefadroxil in treating skin and skin structure infections in children, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). Linezolid demonstrated a higher rate of clinical cure and a shorter duration of symptoms.

Navigating the World of Antibiotic Resistance: A Collaborative Effort

This research highlights the growing challenge of antibiotic resistance and the need for effective treatment strategies. It emphasizes the importance of appropriate antibiotic selection and the need for ongoing research to develop new and effective treatments. Just as a camel relies on its herd for support and guidance, we must work together to combat the threat of antibiotic resistance and ensure that effective treatments remain available for future generations.

Dr. Camel's Conclusion

Treating skin infections in children can be a delicate balancing act, but this research offers valuable insights. Linezolid emerges as a strong contender, particularly for infections caused by resistant bacteria. However, as with any antibiotic, it's important to consult with a healthcare professional to make the best choice for each child.

Date :
  1. Date Completed 2003-06-04
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

12690270

DOI: Digital Object Identifier

10.1097/01.inf.0000059403.21440.2c

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.